Clinical Trial

A Study to Evaluate the Multiple Dose Ascending of PG-033 in Healthy Adult Participants.

Name: A Study to Evaluate the Multiple Dose Ascending of PG-033 in Healthy Adult Participants. — clinical trial record (NCT07619183)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The goal of this study is to evaluate the safety, tolerability and pharmacokinetics (PK) profiles of multiple ascending oral doses(MAD) of PG-033 by directly comparing it with placebo.

Trial Details

NCT Number	NCT07619183
Lead Sponsor	Prime Gene Therapeutics Co., Ltd.
Conditions	Lichen Simplex Chronicus
Enrollment	30 participants
Start Date	2026-06-04
Primary Completion	2026-09-30 (estimated)
Study Completion	2026-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-01